Skip to main content
Erschienen in: Pediatric Nephrology 1/2009

01.01.2009 | Letter to the Editors

Waiting for combined treatment with RAS inhibitors in children with primary glomerulonephritis

verfasst von: Marco Zaffanello

Erschienen in: Pediatric Nephrology | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Excerpt

Therapy with renin angiotensin system (RAS) inhibitors allows reno-protection in patients with glomerulonephritis (GN). Both angiotensin converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) are considered to be the drugs of first choice to improve kidney survival in adults with proteinuric nephropathy. Our knowledge of and interest in these drugs has increased in recent years, as has the number of review articles and publications on the topic. …
Literatur
1.
Zurück zum Zitat Nguyen T, Toto RD (2008) Slowing chronic kidney disease progression: results of prospective clinical trials in adults. Pediatr Nephrol 23:1409–1422CrossRef Nguyen T, Toto RD (2008) Slowing chronic kidney disease progression: results of prospective clinical trials in adults. Pediatr Nephrol 23:1409–1422CrossRef
2.
Zurück zum Zitat MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD (2006) Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 48:8–20CrossRef MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD (2006) Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 48:8–20CrossRef
4.
Zurück zum Zitat Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T (2007) IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18:1880–1888CrossRef Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T (2007) IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18:1880–1888CrossRef
5.
Zurück zum Zitat Borges FF, Shiraichi L, da Silva MP, Nishimoto EI, Nogueira PC (2007) Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome? Pediatr Nephrol 22:1309–1313CrossRef Borges FF, Shiraichi L, da Silva MP, Nishimoto EI, Nogueira PC (2007) Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome? Pediatr Nephrol 22:1309–1313CrossRef
6.
Zurück zum Zitat Zaffanello M, Franchini M, Fanos V (2008) New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy. Pharmacotherapy 28:125–130CrossRef Zaffanello M, Franchini M, Fanos V (2008) New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy. Pharmacotherapy 28:125–130CrossRef
7.
Zurück zum Zitat Simonetti GD, von Vigier RO, Konrad M, Rizzi M, Fossali E, Bianchetti MG (2006) Candesartan cilexetil in children with hypertension or proteinuria: preliminary data. Pediatr Nephrol 21:1480–1482CrossRef Simonetti GD, von Vigier RO, Konrad M, Rizzi M, Fossali E, Bianchetti MG (2006) Candesartan cilexetil in children with hypertension or proteinuria: preliminary data. Pediatr Nephrol 21:1480–1482CrossRef
8.
Zurück zum Zitat Litwin M, Grenda R, Sladowska J, Antoniewicz J (2006) Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol 21:1716–1722CrossRef Litwin M, Grenda R, Sladowska J, Antoniewicz J (2006) Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol 21:1716–1722CrossRef
9.
Zurück zum Zitat Wühl E, Schaefer F (2008) Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol 23:705–716CrossRef Wühl E, Schaefer F (2008) Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol 23:705–716CrossRef
Metadaten
Titel
Waiting for combined treatment with RAS inhibitors in children with primary glomerulonephritis
verfasst von
Marco Zaffanello
Publikationsdatum
01.01.2009
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 1/2009
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-0936-5

Weitere Artikel der Ausgabe 1/2009

Pediatric Nephrology 1/2009 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.